B Lymphocyte Stimulator-specific Inhibitor [EPC]

32030 reported adverse events

These side effects are most commonly reported by patients taking drugs of the B Lymphocyte Stimulator-specific Inhibitor [EPC] class:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 5154
1 SYSTEMIC LUPUS ERYTHEMATOSUS 3979
2 FATIGUE 2095
3 DRUG INEFFECTIVE 1857
4 PAIN 1776
5 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1635
6 HEADACHE 1593
7 NAUSEA 1526
8 MALAISE 1425
9 PRODUCT COMPLAINT 1411
See all common reactions for B Lymphocyte Stimulator-specific Inhibitor [EPC]

Drugs of the B Lymphocyte Stimulator-specific Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLE ARTHRITIS 85 0.2993
1 LUPUS NEPHRITIS 420 0.2244
2 SYSTEMIC LUPUS ERYTHEMATOSUS 3979 0.1120
3 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 77 0.0965
4 BUTTERFLY RASH 64 0.0631
5 PRODUCT COMPLAINT 1411 0.0556
6 EXPOSURE VIA SKIN CONTACT 1029 0.0397
7 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1635 0.0350
8 SOCIAL PROBLEM 87 0.0210
9 PRODUCT DOSE OMISSION ISSUE 5154 0.0175
See all enriched reactions for B Lymphocyte Stimulator-specific Inhibitor [EPC]